Patient P-02442

Synthetic patientMETA-24 · Day 169 · 65–74 · M · baseline S14Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Improving

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

22%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S14

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity-14

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

65 min

improving · +6.4 vs previous 14 d

Sleep duration

Wearable

7.5 h

stable · +0.1 vs previous 14 d

Energy level

Daily log

6.8/10

improving · +0.4 vs previous 14 d

Steps

Wearable

6,266

improving · +610 vs previous 14 d

GI burden

Companion

18.6/100

improving · -3.4 vs previous 14 d

Adherence

Companion

91.2 %

stable · -2.3 vs previous 14 d

Sleep quality

Wearable

61.5/100

stable · +0.6 vs previous 14 d

Glucose, CGM daily mean

CGM

130 mg/dL

stable · +1.1 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 77 from the failing basin, 12 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Simple carbohydrates (supports)
perturbation · steering +5.7
Protein (supports)
perturbation · steering +4.9
Caffeine (supports)
perturbation · steering +3.6
Simple carbohydrates
supporter · GI -3.9 next day
Protein
supporter · GI -2.7 next day

Main detractors to watch

Bacteroides fragilis elevated
hidden · steering -7.4
Poor-sleep week
perturbation · steering -3
Alcohol on dosing days
perturbation · steering -1.8

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Simple carbohydrates
-3.9supporter · 95%
Protein
-2.7supporter · 95%
Caffeine
-2.6supporter · 75%
Ultra-processed food
-1.7no signal · 52%
Alcohol
-0.6no signal · 15%
Insoluble fibre
-0.5no signal · 15%
Dietary fat load
-0.3no signal · 15%
Histamine load
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Inflammatory signalling ↑20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 3.4 · butyrate capacity 67/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 65 ms
Sleep: 7.1 h
Steps: 5,529
Resting HR: 71 bpm

Daily log: GI score 19, nutritional resilience 64, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02441	45%	S11	SC-12	improved	67
P-02462	45%	S12	DT-01	improved	65
P-02620	43%	S01	HY-01	improved	64
P-02698	42%	S06	ME-01	improved	71
P-02082	39%	S12	NP-02	improved	53
P-02218	39%	S01	DT-01	improved	61
P-02586	38%	S18	DT-01	improved	56
P-02127	37%	S11	SC-12	improved	73
P-02167	36%	S02	HY-01	improved	54
P-02147	35%	S13	GI-04	improved	58
P-02538	35%	S02	GI-04	improved	59
P-02685	35%	S16	DT-01	improved	47